Lantheus Holdings, Inc. (LNTH)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Lantheus Holdings, Inc. chart...

About the Company

We do not have any company description for Lantheus Holdings, Inc. at the moment.

Exchange

Nasdaq

$1B

Total Revenue

792

Employees

$5B

Market Capitalization

14.83

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $LNTH News

Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings

6h ago, source: Zacks.com on MSN

Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product ...

Lantheus Holdings, Inc. (LNTH) is Attracting Investor Attention: Here is What You Should Know

2d ago, source:

Lantheus Holdings (LNTH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Here's Why Lantheus Holdings (LNTH) is a Strong Momentum Stock

11d ago, source: Zacks.com on MSN

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Buy Rating for Lantheus Holdings with Strong Growth and Acquisition Potential

8d ago, source:

Yuan Zhi, an analyst from B.Riley Financial, reiterated the Buy rating on Lantheus (LNTH – Research Report). The associated price target ...

Elevance Health (ELV), CD&R to Unveil Primary Care Offering

10d ago, source: Zacks.com on MSN

Elevance Health Inc. ELV inked an agreement with the private investment firm, Clayton, Dubilier & Rice (“CD&R”). The ...

Lantheus Holdings, Inc. (LNTH) Is a Trending Stock: Facts to Know Before Betting on It

15d ago, source:

Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Editorial: Help needed from MBTA, employers to fix commuting

Opinion ago, source:

The number of T passes is down significantly since before the pandemic, and the reason is clear: It’s not cost-effective for ...

Can Higher Visits Soften Cost Blow for Teladoc (TDOC) in Q1?

3d ago, source:

Teladoc's (TDOC) first-quarter results are expected to have benefited from higher visits. However, high costs might have ...

Weitz Large Cap Equity Fund Q1 2024 Commentary

14h ago, source:

The Large Cap Equity Fund's Institutional Class returned +7.79% for the first quarter compared to +10.30% for the Russell ...

Charles River (CRL) to Report Q1 Earnings: Here's What to Expect

2d ago, source: Yahoo Finance

Charles River Laboratories International, Inc. CRL is scheduled to report first-quarter 2024 ... TMDX surpassed earnings in ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...